Global Respiratory Inhalers Market – Industry Trends and Forecast to 2030

Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista  Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Global Respiratory Inhalers Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Upcoming Reports
  • Sep 2023
  • Global
  • 350 Páginas
  • Número de tabelas: 220
  • Número de figuras: 60

Global Respiratory Inhalers Market

Tamanho do mercado em biliões de dólares

CAGR :  % Diagram

Chart Image USD 32,516.50 Million USD 42,107.06 Million 2022 2030
Diagram Período de previsão
2023 –2030
Diagram Tamanho do mercado (ano base )
USD 32,516.50 Million
Diagram Tamanho do mercado ( Ano de previsão)
USD 42,107.06 Million
Diagram CAGR
%
Diagram Principais participantes do mercado
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • CHIESI Farmaceutici S.p.A.
  • GlaxoSmithKline plc
  • Propeller Health

>Global Respiratory Inhalers Market, By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Soft Mist Inhalers, Nebulizer), Patient (Adults, Pediatric), Technology (Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices), Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others), End User (Hospitals, Clinics, Pharmacies, Respiratory Care Center, Other) – Industry Trends and Forecast to 2030.

Respiratory Inhalers Market

Respiratory Inhalers Market Analysis and Size

Respiratory inhalers are used to inhale medicines that are essential part of the treatment for chronic lung diseases. There are numerous products that deliver medicine directly to the airways such as dry powder inhalers, metered-dose inhalers (MDIs), nebulizers and soft mist inhalers. The rapidly increasing prevalence respiratory disorder across the world is amongst the significant factors fueling the growth and demand of global respiratory inhalers market. In addition, the increasing demand for treatment options for respiratory disorders and accessibility of well-developed technologies are also contributing to the growth.

Data Bridge Market Research analyses that the global respiratory inhalers market which was USD 32,516.5 million in 2022, is expected to reach USD 42,107.06 million by 2030, and is expected to undergo a CAGR of 5.87% during the forecast period 2023-2030. This indicates that the market value. “Soft Mist Inhalers” dominates the product segment of the global respiratory inhalers market owing to the rising awareness regarding pulmonary diseases as well as increasing healthcare spending are also lifting the growth of the market.  In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Respiratory Inhalers Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Soft Mist Inhalers, Nebulizer), Patient (Adults, Pediatric), Technology (Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices), Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others), End User (Hospitals, Clinics, Pharmacies, Respiratory Care Center, Other)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa)

Market Players Covered

AstraZeneca (U.K.), Boehringer Ingelheim International GmbH (Germany), CHIESI Farmaceutici S.p.A. (Italy), GlaxoSmithKline plc (U.K.), Propeller Health (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Beximco Pharmaceuticals Ltd. (Bangladesh), 3M (U.S.), Cipla Inc. (India), Koninklijke Philips N.V. (Netherlands), Merck & Co., Inc. (U.S.), Omron Healthcare, Inc. (Japan), Cohero Health, Inc. (U.S.), PARI GmbH (Germany), Glenmark Pharmaceuticals Limited (India), Senzer Ltd (U.K.), Novartis AG (Switzerland), HELTMAN Medikal A.S. (Turkey), Mundipharma International (U.K.)

Market Opportunities

  • Increasing Global Pharmaceutical Production
  • Outsourcing of Quality Control Services

Market Definition

Respiratory inhalers are used to inhale medicines that are essential part of the treatment for chronic lung diseases. There are numerous products that deliver medicine directly to the airways such as dry powder inhalers, metered-dose inhalers (MDIs), nebulizers and soft mist inhalers.

Global Respiratory Inhalers Market Dynamics

Drivers

  • Increasing Prevalence of Respiratory Diseases

The rising incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis is a significant driver for the respiratory inhalers market. The growing global burden of these conditions drives the demand for effective inhalation therapies

  • . Technological Advancements in Inhaler Devices

Advances in inhaler technology have led to the development of more efficient and user-friendly inhalation devices. The introduction of digital inhalers, smart inhalers, and breath-actuated inhalers has improved medication delivery and patient adherence, driving market growth.

Opportunities

  • Expansion in Emerging Markets

Emerging economies offer significant growth opportunities for the respiratory inhalers market. Improving healthcare infrastructure, rising disposable incomes, and increasing awareness of respiratory diseases present a favorable market landscape for inhaler manufacturers.

  • Increasing Focus on Personalized Medicine

The shift towards personalized medicine creates opportunities for tailored respiratory inhaler solutions. Inhalers with customizable dosing, patient-specific treatment plans, and integrated digital technologies can improve patient outcomes and medication adherence.

Restraints/ Challenges

  • Stringent Regulatory Requirements:

Regulatory compliance poses challenges for inhaler manufacturers. Strict regulations regarding safety, efficacy, quality control, and device performance increase the time and cost required for product approvals, hindering market growth.

  • Pricing Pressure and Reimbursement Issues

Pricing pressures, cost containment efforts by healthcare systems, and reimbursement challenges can affect market growth. The availability of generic inhalers and the need for cost-effective treatment options may impact the profitability of inhaler manufacturers.

This global respiratory inhalers market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Respiratory Inhalers market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In September 2022, Beximco Pharmaceuticals launched ONRIVA TRIO BEXICAP which is a dry inhaler capsule. ONRIVA TRIO BEXICAPis indicated as maintainence therapy for asthma

Global Respiratory Inhalers Market Scope

The global respiratory inhalers market is segmented on the basis of product type, patient, technology, disease indication and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Product Type

  • Dry Powder Inhaler
  • Metered Dose Inhaler
  • Soft Mist Inhalers
  • Nebulizer

Patient

  • Adult
  • Pediatric

Technology

  • Manually Operated Inhaler Devices
  •  Digitally Operated Inhaler Devices

Disease Indication

End User

  • Hospitals
  • Clinics
  • Pharmacies
  • Respiratory Care Centre
  •  Other

Global Respiratory Inhalers Market Regional Analysis/Insights

The global respiratory inhalers market is analysed and market size insights and trends are provided by country, product type, patient, technology, disease indication and end user as referenced above.

The countries covered in the Respiratory Inhalers market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is likely to lead the global respiratory inhalers market. The regional market has been driven by the rising cases of chronic diseases such as cancer and increase in medical expenses in the region. However, the sudden boom in cancer diagnosis and the increasing rate of death is the main factor propelling the growth of the regional market.  

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to due to rise in the demand of health insurance policies in densely populated countries such as India and China.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

Global respiratory inhalers market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for respiratory inhalers market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global respiratory inhalers market. The data is available for historic period 2015-2020.

Competitive Landscape and Respiratory Inhalers Market Share Analysis

The global respiratory inhalers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global respiratory inhalers market.

Some of the major players operating in the global respiratory inhalers market are:

  • AstraZeneca (U.K.)
  • Boehringer Ingelheim International GmbH (Germany)
  • CHIESI Farmaceutici S.p.A. (Italy)
  • GlaxoSmithKline plc (U.K.)
  • Propeller Health (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Beximco Pharmaceuticals Ltd. (Bangladesh)
  • 3M (U.S.)
  • Cipla Inc. (India)
  • Koninklijke Philips N.V. (Netherlands)
  • Merck & Co., Inc. (U.S.)
  • Omron Healthcare, Inc. (Japan)
  • Cohero Health, Inc. (U.S.)
  • PARI GmbH (Germany)
  • Glenmark Pharmaceuticals Limited (India)
  • Senzer Ltd (U.K.)
  • Novartis AG (Switzerland)
  • HELTMAN Medikal A.S. (Turkey)
  • Mundipharma International (U.K.)

SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

O mercado é segmentado com base em , By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Soft Mist Inhalers, Nebulizer), Patient (Adults, Pediatric), Technology (Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices), Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others), End User (Hospitals, Clinics, Pharmacies, Respiratory Care Center, Other) – Industry Trends and Forecast to 2030. .
O tamanho do Global Respiratory Inhalers Market foi avaliado em USD 32516.50 USD Million no ano de 2022.
O Global Respiratory Inhalers Market está projetado para crescer a um CAGR de 5.87% durante o período de previsão de 2023 a 2030.
Os principais players do mercado incluem AstraZeneca, Boehringer Ingelheim International GmbH, CHIESI Farmaceutici S.p.A., GlaxoSmithKline plc, Propeller Health, Teva Pharmaceutical Industries , Beximco Pharmaceuticals , 3M, Cipla , Koninklijke Philips N.V., Merck & Co. , Omron Healthcare , Cohero Health , PARI GmbH, Glenmark Pharmaceuticals Limited, Senzer Ltd, Novartis AG, HELTMAN Medikal A.S., Mundipharma International.
O relatório de mercado cobre dados de U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa).
Testimonial